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1. Introduction 
Implantation is a process requiring the delicate interaction between the embryo and a 
receptive endometrium. This intricate interaction requires a harmonized dialogue between 
embryonic and maternal tissues. [Aghajanova et al., 2008; Simon et al., 2000] The three 
stages of implantation are: apposition, adhesion, and invasion. Apposition describes 
trophoblast cells adhering to the receptive endometrial wall. Adhesion to the basal lamina 
and stromal extracellular matrix occurs in the presence of specific hormones, cytokines, and 
adhesion molecules. Once the blastocyst is anchored to the endometrial wall, it will become 
enclosed by an outer layer of syncytiotrophoblast, and an inner layer of cytotrophoblast. As 
the syncytiotrophoblast erodes the endometrium, the blastocyst will burrow into it and 
implantation will occur. [Ganong, 2005] During the last few years, research pursues 
enhancing both the quality of the embryo as well as understanding the highly dynamic 
tissue of the endometrial wall. Despite morphological and chromosomal criteria to improve 
the quality of transferred embryos, implantation rates remain at 25-35%. [Boomsma 
&Macklon, 2006] 
The priming of the endometrium to optimize the window of implantation phase has been a 
subject of interest for decades, and much work has gone into understanding the preparation 
and capability of the endometrial wall to create a hospitable environment for the interaction 
with the blastocyst. While an embryo factor accounts for one third one implantation failure, 
lack of uterine receptivity explains approximately two thirds of implantation failures. 
[Achache, 2006; Ledee-Bataille et al., 2002] The actions of numerous cytokines, hormones, 
immunoglobulins, and other factors, are all orchestrated into preparing the endometrium 
for implantation. The morphological changes towards a receptive endometrium have been 
described as early as 1950 by Noyes, Hertig, and Rock [Strowitzki, 2006] and occur under 
the control of the sexual steroid hormones estrogen, and progesterone; with estrogen being 
the determinant hormone in the proliferative phase and progesterone being the determinant 
hormone in the secretory phase 
During the luteal implantation phase; corresponding to cycle days 20-24, or seven to nine 
days after ovulation, the endometrium is receptive to the oncoming blastocyst. [Goiran & 
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Mignot, 1999] Essential expression of proteins, cytokines, and peptides can be detected at 
this time and serve as biomarkers for maximal endometrial receptivity. [Singh & Aplin, 
2009; Lessey et al., 2002] The detection and investigation of biochemical markers during the 
implantation phase is an area of research receiving much interest and may serve to establish 
future treatments to help maximize the effectiveness of assisted reproductive techniques 
(ART) in the near future. According to Zhu, biomarkers are those that are present in the 
endometrium during the implantation phase, close to the implantation site, and disappear 
thereafter. [Cavagna & Mantese, 2003] This chapter will discuss biomarkers and their role in 
the attachment and invasion process during the implantation phase.  
2. Biomarkers 
HLA-G 
Human leukocyte antigen G (HLA-G) is a major histocompatability complex (MHC) class Ib 
gene thought to play an essential role in implantation by modulating cytokine secretion to 
maintain local immunotolerance and modulate cytokine secretion to control trophopblastic 
cell invasion. [Roussev & Coulam, 2007] At first, HLA-G was proposed as a protector 
against natural killer (NK)-cell-mediated cytolysis of target cells and to prevent 
allorecognition by maternal cytotoxic lymphocytes. Recently, it has been shown tha these 
proteins regulate immune cells including T cells, NK cells, and antigen-presenting cells. 
[Fournel, 2000] Due to its essential role in the implantation process, recent attention has been 
focused on HLA-G and its diagnostic and therapeutic clinical applications. This has 
included the evaluation of couples with recurrent miscarriages and the mutation of the 
HLA-G gene. Serum sHLA-G levels during pregnancy may in the future become a 
diagnostic tool for evaluation of successful implantation but has yet to be established. 
[Roussev & Coulam, 2007]  
Pinopodes 
Pinopodes are organelles shown to be present on the endometrial wall during the 
implantation phase. They have been detected by electron microscopy and are specific 
markers for uterine receptivity. Progesterone dependent, pinopodes are present 20-21 days 
into the luteal cycle. [Cavagna & Mantese, 2003] Their function has not fully been 
established, but pinopodes are thought to play a role in protecting the blastocyst from being 
swept by the cilia on the endometrial wallpromoting withdrawal of uterine fluid and 
facilitating molecular adhesion of the pinopodes with the blastocyst. The life span of fully 
developed pinopodes lasts no more than 48 hours suggesting a transient cell state. 
Following ovarian stimulation with clomiphene citrate and human chorionic gonadotropin 
(hCG), pinopodes formed a little earlier, on days 17 or 18 than in the natural state.. [Cavagna 
& Mantese, 2003] It is thus possible that ovarian stimulation and early pinopode formation 
may have a role in shifting the window of receptivity resulting in asynchrony between the 
endometrium and blastocyst thereby negatively influencing implantation rates with IVF.  
Integrins 
Integrins are a family of transmembrane glycoproteins, formed by the interaction of two 
different, non-covalently linked ┙ and ┚ subunits. [Achache & Revel, 2006] They are 
adhesion molecules which participate in cell-adhesions and have also shown to play part in 
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adhesions between cells and extracellular components. [Ceydell, 2006] In addition, integrins 
participate in many physiologically important processes including embryological 
development, haemostasis, thrombosis, wound healing, immune and non-immune defense 
mechanisms and oncogenic transformation. Specifically, the ┙v┚3 integrin as well as its 
ligand osteoponin was positively detected by immunohistochemistry on the endometrial 
luminal epithelial surface, which first interacts with the trophoblast. [Achache & Revel, 2006; 
Apparao ET AL., 2001] The expression of the endometrial stromal integrins may be 
modulated by several factors and the expression of the ┙v┚3 integrin in the endometrial 
stroma was demonstrated to be stimulated by IL- ┙, IL- ┚ and TNF-┙. [Ceydell, 2006] 
Integrins have been proposed as markers for endometrial receptivity, and the ┙v┚3 
glycoprotein particularly has been directly associated with implantation.  
L-selectin 
Selectins are lectin like proteins and include E-, L-, and P-selectins, all of which were 
originally thought o be expressed solely by hemangioblast descendants. P- selectins are 
expressed on the surface of platelets, E- selectins are expressed on activated endothelial 
cells, and L-selectins are expressed on lymphocytes. Glycoproteins carrying oligosaccharide 
formations including CD34, GlyCAM-1, PSGL-1, podocalyxin, and endoglycan, are 
recognized by the selectin molecules. [Foulk et al., 2007] Selectins are responsible for the 
tether and roll mechanism on endothelial surfaces. Once leucocytes slow down and 
subsequently arrest, integrin activation triggers adhesion and transmigration through the 
vascular endothelium. [Torry et al., 2007] Recently, Genbacec et al. [Genbacev et al., 2003] 
have shown that hatched blastocysts expressed L-selectin and used this molecule to mediate 
its attachment to the luminal epithelial surface via MECA-79, its carbohydrate ligands, and 
related epitopes. [Foulk et al., 2007] Also, Foulk and Zdravkovic have shown that lack of 
expression of the L-selectin ligand MECA-79 in mid-luteal endometrial biopsies were 
indicative or low or no chance of pregnancy.  
Heparin binding-epidermal growth factor 
Heparin binding-epidermal growth factor (HB-EGF) interacts with the EGF receptor and 
belongs to the epidermal growth factor family. It has been shown that HB-EGF expression 
is low during the proliferative endometrial phase, attaining its highest measure 
immediately prior to the implantation window, suggesting that it may have a role during 
the blastocyst implantation process. [Cavagna & Mantese, 2003; Lessey et al., 2002] It has 
been suggested that HB-EGF promotes implantation and trophoblast invasion through 
paracrine/autocrine signaling as cells penetrate the stroma. HB-EGF has also been shown 
to inhibit apoptosis and induces an invasive trophoblast phenotype. The co-existence of 
HB-EGF and pinopodes has been investigated with electron microscopy and 
immunochemistry, and shows that the expression of HB-EGF is highest when fully 
developed pinopodes are present, supporting the role of HB-EGF in the implantation 
process. [Cavagna & Mantese, 2003, Stavreus et al., 2001]  
Chorionic gonadotropin and Notch 1 
Chorionic gonadotropin is one of the early embryonic secretions from the trophoblast cells 
of the pre-implantation embryo. This helps maintain the corpus luteum of pregnancy, and 
leads to the modifications in morphology and endometrial gene expression preparing for 
implantation.  
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The notch family of receptors mediates a highly conserved pathway that regulated 
differentiation and pro-survival signals from humans to varied species of invertebrates. 
[Afshar et al., 2007; Paria et al., 2002] Notch proteins are ligand-dependant transmembrane 
receptors that transduce extracellular signals responsible for cell-fate and differentiation 
throughout development. Notch signaling often restricts the differentiation fates of a cell, 
directing it to a specific cell fate in cooperation with other signals, while at the same time 
inhibiting differentiation toward an alternate fate and promoting survival. Evidence indicates 
that Notch signaling regulates all three branches of the fate cell decision tree; differentiation, 
cell cycle progression and apoptotic cell death. Recently Afshar et al. have shown the co-
expression of ┙SMA and Notch 1, both arising from CG signaling, inhibits apoptosis of 
stromal cells during the establishment of pregnancy. Shedding of the uterine lining and the 
inability of the uterus to accept an embryo can be correlated with low expression of Notch 1. 
Survival of the uterine lining can be mediated by (h)CG supplementation or progesterone as 
they will induce the expression of Notch 1. [Afshar et al., 2007] 
Mucins 
Mucins are glycoproteins high in molecular weight, which contain at least 50% of 
carbohydrate O-linked to a theonine/serine rich peptide core. [Gendler et al., 1990] MUC-1 
is a large glycoprotein with a molecular weight >250 kDa. [Achache & Revel, 2006] When 
highly expressed on a cell surface, MUC-1 produces a steric hindrance phenomenon 
interfering with cellular adhesion. Cell-cell and cell-matrix adhesions are inhibited in direct 
correlation to the length of the MUC-1 ectodomain. [Hilkens et al, 1992] The apical surface of 
most epithelial cells is protected by a thick glycocalyx composed mostly of mucins that are 
believed to protect the cell surface from pathological processes. In the endometrium, MUC-1 
is probably the first molecule the blastocyst encounters on the endometrial wall before 
implantation. This interaction would seem to indicate the blastocyst might be deterred from 
the endometrial wall until a proper location is encountered for implantation. In mice, rats, 
and pigs it has been shown that MUC-1 is down-regulated during the window of receptivity 
and thus optimizing the interaction between blastocyst and uterine wall. Paradoxically in 
humans, it has been shown that MUC-1 is up-regulated during the pre-implantation period. 
Therefore, it was suggested that humans must have a mechanism to induce inhibitory 
factors to down-regulate the MUC-1 barrier. High progesterone levels apparently reduce 
MUC-1 levels, thus unmasking intracellular adhesion molecules (CAM) on the surface of the 
endometrium and increasing uterine receptivity. [Bowen et al., 1996] Immunohistochemistry 
and scanning electron microscopy have shown that the MUC1 epitope corresponds only to 
ciliated cells. But the surface of non-ciliated cells such as pinopods has not been correlated to 
MUC-1. It has been suggested that pinopodes are important in providing a MUC-1 free area 
for blastocyst implantation. It seems that even though MUC-1 appears to have negative 
effects on implantation, its upregulation and extension beyond the glycocalyx covering the 
endometrium suggest it may have a temporary role in directing the embryo to effective 
implantation. [Achache & Revel, 2006] 
Calcitonin 
Parafollicular cells of the thyroid release calcitonin in response to hypercalcemia to reduce 
calcium levels. Though its role remains to be determined, calcitonin is expressed in the 
human endometrium during the secretory phase with highest concentrations on luteal cycle 
days 19-21, coinciding with the implantation period. It has also been demonstrated 
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progesterone induces calcitonin gene expression in the endometrium. [Cavagna & Mantese, 
2003; Kumar, 1998] By immunoreactivity for calcitonin mRNA,calcitonin seems to be absent 
during the proliferative and ovulatory phase. This finding may be another reason to suspect 
that calcitonin may be a marker for uterine receptivity. Calcitonin controls calcium 
homeostasis by binding to specific receptors identifeied as CR1a and CR1b. [Sexton et al., 
1993; Wang, 1998] CR1a receptors have been found to be present in murine oocytes and 
zygotes in low concentrations, but significant increase of this receptor was found in embryos 
between the 8 cell and blastocyst stage. Wang et al. have also shown blastocysts differentiate 
in vitro at an accelerated rate when treated with 10 nM calcitonin for 30 minutes. [Cavagna 
& Mantese, 2003; Wang, 1998] Though this seems to demonstrate the role of calcitonin in 
embryonic development, further studies will need to be conducted to show the definitive 
role of calcitonin during implantation and development of the embryo.  
Prostaglandins  
As implantation takes place, the blastocyst needs access and connection to the maternal 
vascular system. For this to occur there needs to be an increase of vascular permeability at 
the site of implantation. [Chakraborty et al., 1996] Prostaglandins (PGs) are known to 
possess vasoactive factors,play a definitive role in ovulation, fertilization, and labor, and 
recently have shown to be crucial during the implantation process. [Achache & Revel, 2006, 
Song et al., 2006]  
Prostaglandins are eicosanoids consisting of four members, PGD2, PGE2, PGF2┙, and 
prostacyclin (PGI2). These are generated by the action of two enzymes, cytosolic 
phospholipase A2 (cPLA2), and cyclooxygenase (COX). Song et al. have demonstrated 
female mice lacking the cPLA2 and COX enzymes are not able to produce PG, leading to 
significant implantation defects. cPLA2 knockout mice also exhibited pregnancy failures 
and small litter size, secondary to delayed implantation. Exogenous administration of PG 
was able to restore embryo implantation at the correct time. It is not clear whether 
diminished expression of PG prevents human fertility because mice lacking PG will be 
fertile but present with fine tuning details. Thus it is postulated a similar process in humans 
leading to delayed implantation could lead to early pregnancy loss. Further investigation on 
the role of PGs at the time of human implantation and its possible role in late-pregnancy 
abnormalities needs to be further explored. [Achache & Revel, 2006, Song et al., 2006] 
HOX genes 
Homeobox genes HOXA-10 and HOXA-11 have been linked with endometrial receptivity. 
Mutations in these genes have lead to failure to achieve normal implantation in mice. 
[Cavagna & Mantese, 2003; Daftary & Taylor, 2001] Growth and development of the human 
endometrium have been linked with these genes, and shown to have significant up-
regulation in the mid-secretory phase correlating with the implantation window. Female 
mice with homozygous mutations in the HOXA-10 or HOXA-11 have been shown to be 
infertile due to endometrial factors. [Satokata et al., 1995] According to Benson et al., the 
HOXA-10 gene may be important during morphogenesis for proper patterning of the 
reproductive tract and in adult endometrium for adequate implantation events.  
In women with endometriosis, Taylor et al. observed HOX gene expression is altered 
resulting in endometrial molecular alterations resulting in decreased endometrial 
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receptivity. These observations further support the importance HOX gene expression may 
have during implantation process.  
Angiogenesis 
Vascular development at the maternal fetal interface is an essential component for 
successful implantation and development. Trophoblasts, natural killer cells, and other cell 
types are responsible for this development. Trophoblasts are well known to produce 
angiogenic growth factors. [Cross et al., 2002; Torry et al., 2007] Ungranulated uterine 
natural killer cells (uNK) precursors are recruited to the endometrium during the transition 
of the endometrium to the secretory phase. Progesterone allows the development of the pre-
uNK into large granulated uNK cells. These appear to be present during the implantation 
phase and have a role in releasing cytokines responsible for angiogenesis in early 
pregnancy, and development of spiral arteriole formation as the pregnancy progresses. 
[Leonard et al., 2006] In vitro models of mice have suggested that progesterone serves to up-
regulate decidua IL-15, in turn serving as a main activator of uNK population. [Leede-
Bataille et al., 2005]  
Other cells such as B and T lymphocytes have also been implicated in angiogenesis during 
the early phases of pregnancy. B lymphocytes have been shown to express the c-Myc 
oncogene, which can induce angiogenesis by producing VEGF. [Ruddell et al., 2003] 
Vascular endothelial growth factor (VEGF) is a known angiogenic substance involved in the 
process of vascular proliferation. [Tammela et al., 2005] During the peri-implantation 
phases, certain VEGF receptors appear to be expressed and function to optimize blastocyst 
implantation by mediating vascular permeability. These are VEGFR-1, VEGFR-2, and NRP-
1. [Halder et al., 2000; Torry et al., 2007] The function and expression of VEGF have shown 
to be pivotal for angiogenesis during the implantation process and early placental 
development. Disturbance of this process could lead to implantation failure and early 
pregnancy loss.  
Insulin like growth factor-II (IGF-II) 
Insulin-like growth factors along with their binding proteins are thought to be responsible 
for differentiation, endometrial growth, angiogenesis, and apoptosis. [Cavagna & Mantese, 
2003] IGF-II in particular is a known mediator of trophoblast function and is required for 
suitable placental growth and transport function. [Herr et al., 2003] Trophoblasts havebeen 
shown to express IGF-II while vessels near the implantation site have similarly been shown 
to expresses IGF-II receptors indicating IGF-II may directly act as an angiogenic growth 
factor. [Torry et al., 2007] In mice, IGF-II has demonstrated its vessel proliferation potential 
by inducing angiogenic growth factors such as VEGF and proliferin. Insulin like growth 
factors are regulated by insulin-like growth factor binding proteins (IGFBP). [Cavagna & 
Mantese, 2003] Litcht et al. have shown that secretion of IGFBP-1 by the endometrium 
occurs approximately 10 days after the LH surge, correlating with the implantation window. 
[Licht et al., 2002] With IGFBP-1 being the predominant regulatory factor for IGF-II, it may 
play an important role in endometrial receptivity and implantation. 
Leukemia Inhibitory Factor (LIF) 
In 1992, Hilton demonstrated LIF to be a haemapoietic factor by its capability to stimulate 
macrophage differentiation of the mouse myeloid leukemia cell line. [Achache & Revel, 
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2006; Hilton, 1992] Proliferation, cell survival, and differentiation, are some of the autocrine 
and paracrine effects of LIF, and have led researchers into investigating its function in 
blastocyst development and implantation. A study by Stewart [Stewart, 1994] showed that 
female mice expressing homozygous LIF gene deficiency displayed failed embryo 
implantation. Further evidence of the importance of LIF was observed as LIF 
supplementation rescued embryo implantation in the previously affected mice. LIF 
expression was observed to reach maximum concentrations in the mid- to late-secretory 
phase. Endometrial biopsies have shown LIF mRNA expression on days 18 to 28 of the 
menstrual cycle with maximum expression on day 20. [Charnock-Jones et al., 1994] Infertile 
patients and those with repeated implantation failureshave been shown to have abnormal 
levels of LIF supporting the role of LIF as a fundamental element in the implantation 
process. [Achache & Revel, 2006] Preclinical and clinical trials have investigated the effects 
of recombinant human LIF (r-hLIF) in improving endometrial receptivity. [Brinsden et al., 
2003] In light of the importance of LIF in the implantation process, r-hLIF could be an 
important tool in the near future to optimize endometrial receptivity.  
Serum-and Glucocorticoid-Regulated Kinase 1 (SGK1) 
Recently, Feroze-Zaidi el al. demonstrated that women with unexplained fertility or 
recurrent implantation failure after IVF showed an abnormal expression of the SGK1 gene in 
the luminal epithelial cells during the midsecretory receptive phase corresponding with the 
implantation window. [Fakhera et al., 2007] Regulation of epithelial Na+ channels (ENaCs) 
is known to be controlled by SGK1. Uterine fluid homeostasis could thus be directly 
influenced by SGK1 leading to decreased uterine receptivity and disruption of successful 
implantation. Differentiating human endometrial stromal cells (HESCs) also activate SGK1, 
which stimulates the expression of prolactin (PRL), a most important decidual marker gene. 
[Brosens & Gellersen, 2003, 2006]  
FOXO proteins are known to be able to regulate genes involved in proaptotic properties, 
and also genes involved in differentiation, cell cycle arrest, DNA repair, and oxidative 
defenses. [Fakhera et al., 2007; Sunters et al., 2003] Phosphorylation of transcription factors 
regulating expression of FOXO proteins, are targeted by kinases including SGK1 which 
serve to inactivate such proteins. [Brunet et al., 2001; Rena et al., 2003] Increased activity of 
SKG1 in the midsecretory phase may disrupt implantation by disrupting normal activity of 
ENAC-mediated Na+ and water transport or by interrupting focal apoptosis.  
Interleukin-6 (IL-6) 
IL-6 is a cytokine classically known to induce immunoglobulin production in activated B 
cells, but also found to display a wide variety of functions outside the B-lymphocyte system. 
IL-6 expression in the human endometrium has been detected with the highest levels 
corresponding to the luteal phase. [Achache & Revel, 2006] mRNA expression of IL-6 
steadily increases during the mid- to late-secretory phase and then decreases again in the 
late-secretory phase. During the crucial window of implantation, immunoreactivity for IL-6 
becomes markedly detectable. The epithelial and glandular cells are the areas where the 
protein is mostly pronounced, compared to the stroma. During the window of implantation, 
receptors for IL-6 can be found not only in the endometrium, but are also expressed in the 
blastocyst, suggesting the paracrine/autocrine role of IL-6 during the peri-implantation 
period. Experiments performed using mice with disrupted IL-6 genes have shown despite 
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implantation , the growth and development of the blastocyst becomes compromised. 
[Achache & Revel, 2006; Salamonsen et al., 2000] This suggests that even though IL-6 may 
not be an essential element for implantation, the lack of its presence could still explain 
infertility in some cases. Recent findings of patients with recurrent abortions have shown 
that IL-6 endometrial m-RNA is suppressed in the mid-secretory phase, thus supporting the 
role and importance of IL-6 in infertility. 
Interleukin-1 (IL-1) 
IL-1┙, IL-1┚, and IL-1 receptor antagonist (IL-1ra) are all included in the family of IL-1, and 
serve as pivotal mediators of the immunologic and inflammatory response. In past 
experiments with mice, knockout mice for IL-1 were still able to proceed with implantation, 
but of interest, mice who received intraperitoneal injections of the IL-1ra displayed 
blastocysts unable to implant on the endometrial wall. Simon attributed this to the down 
regulation of crucial integrins at the luminal epithelial surfaces by the IL-1ra. In humans, it 
has been observed that administration of IL-1 causes an increase of ┚3 expression in the 
culture media of EECs thereby optimizing blastocyst implantation. [Achache & Revel, 2006] 
Leptin has also been shown to increase integrin ┚3 expression. Interestingly enough, IL-1┚ 
acts in stimulating leptin secretion and up-regulating its Ob-R receptor in EECs. IL-1 RtI 
mRNA and protein have shown to be present in maximal levels during the luteal phase in 
the human epithelial endometrium, and expression of the IL-1 antagonist has been shown to 
be reduced during the period of the implantation window. This finding suggests that 
suppression of the IL-1 antagonist during this crucial period of implantation maximizes 
successful implantation. [Boucher et al., 2001]  
In women with endometriosis, the levels of IL-1ra and IL-1┙ were found to be markedly 
increased when compared to control groups in the PF and serum, and may serve as an 
explanation of the pathogenesis and infertility in such patients. [Kondera-Anasz et al. 2005]  
Leptin 
Acting both at the endocrine and paracrine level, leptin has been associated with regulation 
of body weight and reproductive function. [Cervero et al., 2004] Leptin is the product of the 
OB gene. Studies with rodents have determined this ligand-receptor system to be necessary 
for implantation. Receptors associated with leptin include total leptin receptor (OB-RT), the 
long form (OB-RL), and HuB219.1 and HuB219.3 short isoforms found in the endometrium. 
Studies with mice expressing ob/ob mutations resulted in phenotypically obese and sterile 
mice. Exogenous leptin treatment was able to restore sterility in these mice, but food 
restriction was not, implicating leptin as a requirement for normal reproductive functioning. 
[Cervero et al., 2004] Additionally, leptin has also been shown to increase integrin ┚3 
expression, an important ligand protein essential for endometrial receptivity and 
implantation. The leptin receptors OB-RT, OB-RL, HuB219.1, and HuB219.3 have all 
demonstrated maximal expression in the late luteal phase. [Achache & Revel, 2006]  
Cadherins 
Cadherins are responsible for calcium-dependent cell-to-cell adhesion mechanisms and 
belong to a group of glycoproteins divided into N-, P-, and E-cadherins, all displaying 
specific functions and tissue distributions. Of all the cadherins, E-cadherin is the most 
studied pertaining to implantation, is ubiquitous, and is believed to be responsible for 
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maintainance of adherens junctions in epithelial cells. [Singh & Aplin, 2009] E-cadherin 
suppression is responsible for cell-cell adhesion dysfunction. Riethmacher et al. 
demonstrated that targeted mutation of the E-cadherin gene resulted in defective pre-
implantation development in mice.  
During the luteal phase, E-cadherin mRNA levels are significantly elevated and 
regulation seems to be mainly controlled by intracellular calcium levels. E-cadherin 
cytoskeletal organization and disassembly at the adherens junction are mediated by rising 
levels of calcium which work by acting on signaling pathways. In vitro studies have 
shown that calcitonin produces a transient rise in intracellular calcium levels, suppressing 
E-cadherin at cellular contact sites. These experiments were performed by Li et al. on 
cultured Ishikawa cells.  
Calcitonin appears to be an important regulator of implantation. Progesterone acts to 
increase calcitonin levels, which in-turn acts to increase intracellular calcium thus regulating 
E-cadherin expression. E-cadherin then seems to serve two main functions of uterine 
receptivity: adhesiveness in the preliminary phases; and inactivation by the actions of 
progesterone and calcitonin in the secretory phase to allow epithelial cell disassociation and 
implantation. [Achache & Revel, 2006]  
Cyclin E and p27 
Cyclins are known to control mitotic phase progression in cells. The G1 to S phase transition 
is controlled by the rate limiting step of Cyclin E, whereas prevention of the cell cycle 
progression is controlled by the p27 cyclin-dependent kinase inhibitor. [Kliman et al., 2006] 
While the plausible role of cyclin E involves proliferation, p27 is mostly responsible for 
differentiation. [Dubowy et al., 2003] Conbsistent with these actions, estrogen has positive 
regulatory effects on Cyclin E andprogesterone seems to induce a dominant p27 state. 
Cyclin E activity is present in the cytoplasm of epithelial cells whereas p27 activity is 
exclusively active in the nucleus. While present in the early phases of the mestrual cycle, 
Cyclin E reactivity seems to rapidly decrease after cycle day 19; this could be explained by 
its subsequent movement towards the nucleus where it binds to p27 thereby becoming 
inactivated.  
The Endometrial Function Test (EFT) is a means to assess Cyclin E by 
immunohistochemically staining endometrial biopsies using antibodies against Cyclin E; 
and also as a means to identify an abnormally developing endometrium. [Dubowy et al., 
2003] EFT showing a persistence of Cyclin E was associated with glandular developmental 
arrest (GDA), and observed in women with infertility. The overexpression of Cyclin E 
seemed to indicate that cells were arrested at an earlier phase of the menstrual cycle, 
possibly due to a premature expression of p27. [Kliman et al., 2006] The development of the 
EFT associated with cyclin markers and their correlation to estrogen and progesterone could 
serve as an important tool in the near future to assess endometrial receptivity and the effects 
of exogenous hormone administration in infertile patients. [Kliman et al., 2006]  
Colony Stimulating Factor-1 (CSF-1) 
CSF-1 is a haemopoietic growth factor inducing proliferation and differentiation of cells 
belonging to the mononuclear phagocytic lineage. Pollard et al. have demonstrated that 
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op/op mice with mutations in CSF gene displayed multiple skeletal defects and decreased 
implantation rates. Other studies have shown CSF-1 to also be an important factor when it 
comes to ovulation. Op/op mice compared to wild type mice showed significant lower 
follicular development and ovulation rates. It has been shown that women with lower 
preconceptional CSF-1 levels are more prone to recurrent abortions compared to women 
with higher preconceptional CSF-1 levels. [Cavagna & Mantese, 2003]  
2. Clinical implications 
Continuing investigation into understanding and exploring new markers of endometrial 
receptivity remain a high priority in reproductive endocrinology. Recent studies performed 
by Haouzi and associates have found new genes expressed during the implantation window 
by the human endometrium. [Haouzi et al., 2009] This information along with knowledge of 
previously discussed biomarkers can lead investigators to a more thorough approach when 
performing endometrial biopsies during a natural cycle especially in patients who have had 
unsuccessful IVF cycles. The goal of such investigation is to better understand the 
requirements of a hospitable environment for blastocyst implantation. Such knowledge may 
decrease unsuccessful implantation and facilitate a single embryo transfer in a well known 
receptive environment during an IVF cycle. 
3. Future applications  
With recent significant attention given to endometrial receptivity, it is with no surprise that 
new methods of investigating the endometrial factor are under investigation and may soon 
become routine when exploring causes for infertility. Recently performed studies have now 
started to analyze endometrial secretions prior to embryo transfers in IVF and IUI patients. 
[Boomsma et al., 2009] Recent research conducted by Boomsma and associates evaluated 
secretions of different cytokines including interleukins, tumor necrosis factor-┙, macrophage 
migration inhibitory factor, eotaxin, monocyte chemotactic protein-1, and heparin-binding 
epidermal growth factor. [Boomsma et al., 2009] Such novel modalities may soon elucidate 
new therapies and treatments of defective endometrial receptivity.  
4. Conclusion 
With the precisely timed roles of different cytokines, hormones, and immune regulatory 
mechanisms, implantation is an intricate process requiring the collaboration of synchronized 
timed events and chemical interactions. As previously discussed, the “window of 
implantation” corresponds to a short period of time between days 20 and 24 of the 
menstrual cycle when the endometrium becomes receptive to the oncoming blastocyst. 
During the first part of the menstrual cycle, estrogen is present as the predominant hormone 
causing endometrial cell proliferation. Progesterone secreted by luteinized follicles after 
ovulation in the latter phase of the menstrual cycle serves to induce cell differentiation.  
Approximately five-six days after ovulation, the blastocyst will enter the uterine cavity in 
search of a well prepared endometrium for implantation. Biomarkers such as the ones 
previously discussed are vital to ensure this process is successful. Selectins and mucins 
play a role in leading the blastocyst to a receptive endometrium , while integrins and 
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cadherins serve as adhesion molecules for nidation. This fine orchestration of biomarkers 
and timed events has lead scientists toward improved understanding of the endometrium 
and its role during implantation. During the last decades, many advances have been made 
to improve ovulation and the quality of embryos. While remarkable advances such as IVF 
and other ART have been achieved, scientists are starting to realize the importance of a 
“fertile ground” at the embryo-uterus interface. Current research leading to the better 
understanding of biomarkers and endometrial receptivity may lead to optimization of 
embryo implantation in the future. Screening for receptivity markers and treating patients 
accordingly may allow for increasing use of a single embryo transfer with IVF leading to 
fewer complications encountered from multiple gestations. Patients will in tandem benefit 
by avoiding high costs of recurrent ART treatments and emotional despair from failed 
procedures. Some physicians are already taking proactive approaches in assessing 
endometrial receptivity by assessing biomarkes such as integrins, cyclin E, p27, and 
recently, even genes from endometrial biopsies. Such screenings may be standard in the 
near future and may lead to favorable treatments with subsequent higher rates of 
successful implantation.  
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